A PTN-Rich MSC Subtype Promotes Cartilage Repair in End-Stage Knee Osteoarthritis
Ziwei Wang, Luxu Yin, Fuchang Zhao, Dan Liu, Jingyu Li, Jing Chu, Zhengtong Zhou, Hui Liu 等 17 位
Shandong Provincial QianFoShan Hospital Shandong First Medical University
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
SUMMARY Mesenchymal stem cell (MSC) therapy for end-stage knee osteoarthritis (KOA) shows inconsistent efficacy, and whether MSCs retain cartilage repair capacity in the inflammatory joint remains unclear. Using single-cell RNA sequencing of human Kellgren-Lawrence grade III (G III) and IV (G IV) KOA joint tissues and exogenous MSCs, we found that pleiotrophin (PTN) signalling shifts from MSC-chondrocyte crosstalk to chondrocyte-dominated autocrine signalling, with PTN exhaustion and elevated cluster of differentiation 74 (CD74) in G IV cartilage. We therefore identified and sorted a PTN-rich CD74-low placenta-derived MSC subtype and evaluated it in a murine KOA model and in co-culture with patient-derived chondrocytes. This subtype enhanced cartilage repair, upregulated SOX9, and suppressed MMP13, CD74, IL-6, and IL-1β, potentially through CD74 suppression and reduced NF-κB signaling. These findings provide a basis for functionally defined, stage-matched cell therapy tailored to the pathological microenvironment of end-stage KOA. HIGHLIGHTS Grade IV cartilage shows pleiotrophin exhaustion and elevated CD74-driven inflammation A sorted PTN-rich CD74-low placental mesenchymal stem cell subset The subset reactivated endogenous chondrocyte repair, raising SOX9, lowering MMP13 Joint-localized cells persisted 70 days, supporting stage-matched precision therapy
逐年被引趋势
暂无年度引用数据
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Osteoarthritis Treatment and Mechanisms
Mesenchymal stem cell research · Periodontal Regeneration and Treatments